The PennZone

  • Home
  • Business
  • Non-profit
  • Health
  • Technology
  • Travel
  • Real Estate
  • Construction
  • Legal

SafeBreak® Vascular Cleared for Pediatrics
The PennZone/10232295

Trending...
  • Norisia Launches AI Formulated Luxury Multivitamin to Transform Daily Wellness in the UK
  • NASA / Glenn Research Center Collaboration to Help Meet Rising Demand for Space Energy Beaming Tech / CIGS PV Modules from Ascent Solar: NAS DAQ: ASTI
  • HBMHCW Expande Infraestructura de Cumplimiento para Argentina mientras América Latina Supera $1.5 Billones en Volumen Cripto
SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line Lineus Medical
FAYETTEVILLE, Ark. - PennZone -- Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients. SafeBreak Vascular has been shown in adult clinical studies to reduce IV complications with its innovative breakaway technology1.

SafeBreak Vascular is the first breakaway device cleared by the FDA and proven to reduce IV complications in adults by 44%1. It fits between the IV tubing from the IV pump and the patient's IV access point at the arm. When there is a damaging force on the line, SafeBreak separates to protect the patient's IV. This innovative feature helps prevent accidental dislodgement of the catheter, as well as other IV complications caused by damaging forces on the IV line1. This is especially important for pediatric patients who may be more active, less inclined to follow instructions, and less aware of their surroundings.

More on The PennZone
  • VC Fast Pitch Is Coming to Maryland on March 26th
  • Patent Bar Exam Candidates Achieve 30% Higher Pass Rates with Wysebridge's 2026 Platform
  • Municipal Carbon Field Guide Launched by LandConnect -- New Revenue Streams for Cities Managing Vacant Land
  • Hoy Law Wins Supreme Court Decision Establishing Federal Trucking Regulations as the Standard of Care in South Dakota
  • Dr. Rashad Richey's Indisputable Shatters Records, Over 1 Billion YouTube Views, Top 1% Podcast, 3.2 Million Viewers Daily

"We are incredibly proud to receive clearance from the FDA for the use of SafeBreak Vascular with pediatric patients," said Vance Clement, CEO of Lineus Medical. "SafeBreak provides a simple, effective solution for preventing IV complications, which reduces IV restarts and additional needlesticks for patients.  Now, it doesn't matter if the patient is 1 or 100 years old, SafeBreak is cleared for use on all peripheral IVs.  Our goal is to have a SafeBreak on every IV line, everywhere in the world, and this additional clearance lets us help one of the most vulnerable populations that needs it the most, our kids."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a unique, patented, break-away technology that is designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and any other type of medical tubing may be reduced as breakaway devices separate to protect the patient. More information about Lineus Medical can be found on the company website:  www.lineusmed.com or you can follow the company on Twitter or LinkedIn.

1 Dipper Study Data on File

MKG-0194 REV 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Iranian-Born Engineer Mohsen Bahmani Introduces Propeller-Less Propulsion for Urban Air Mobility
  • Aleen Inc. (C S E: ALEN.U) Advances Digital Wellness Vision with Streamlined Platform Navigation and Long-Term Growth Strategy
  • RimbaMindaAI Officially Launches Version 3.0 Following Strategic Breakthrough in Malaysian Market Analysis
  • Fed Rate Pause & Dow 50k: Irfan Zuyrel on Liquidity Shifts, Crypto Volatility, and the ASEAN Opportunity
  • 20/20 Institute Launches Updated Vision Correction Procedures Page for Denver & Colorado Springs
  • OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors
  • New Children's Picture Book "Diwa of Mount Luntian" Focuses on Calm, Culture, and Connection for Today's Families
  • Actor, Spokesperson Rio Rocket Featured in "Switch to AT&T" Campaign Showing How Customers Can BYOD and Keep Their Number
  • The World's No.1 Superstar® Brings Disco Fever Back With New Global Single and Video "Disco Dancing"
  • Boston Industrial Solutions' Natron® 512N Series UV LED Ink Achieves BPA Certification, Advancing Safe and Sustainable Digital Printing
  • Joan Nissen promoted to Century Fasteners Corp. – General Manager, Aerospace & Government Sales
  • Northwest Modern Fabrication Expands Manufacturing Capacity With 4,800 Sq. Ft. Addition
  • NRE-HEALTH Radio Launches With a New Approach to Health Broadcasting
  • From Coffee to Commutes: sMiles App Now Pays Bitcoin for Every Gift Card Purchase
  • Finland's Health Authority Launches '2-4-2' Gambling Risk Limits Ahead of Expected Advertising Boom
  • Dr. Billy B. Laun II Addresses Over 120 Dental Professionals at Annual Dental Meeting
  • CCHR: Taxpayer Billions Wasted on Mental Health Research as Outcomes Deteriorate
  • Digital Efficiency Consulting Group (DECG) Officially Launches
  • Work 365 Delivers Purpose-Built Revenue Operations for Microsoft Cloud for US Government
  • Meridianvale Unveils QarvioFin Public Beta: The First 'Glass Box' AI Operating System for Autonomous Finance

Popular on PennZone

  • Mark Schork Selected As 'Board Observer' By Philadelphia Bar Foundation - 144
  • Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
  • High-End Exterior House Painting in Boulder, Colorado
  • Michael Judkins Releases New Poetry Book, Deeper Than You Think
  • $780,000 Project for New Middle East Police Service with Deposit Received and Preliminary Design Work Underway for Lamperd: Stock Symbol: LLLI
  • New Year, New Home: Begin 2026 at Heritage at South Brunswick
  • Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value
  • Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto
  • High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
  • Reputation Management Services Expanded

Similar on PennZone

  • Yazaki Innovations to Introduce First-Ever Prefabricated Home Wiring System to U.S. Residential Market in 2026
  • Ace Industries Welcomes Jack Polish as Controller
  • Senseeker Machining Company Acquires Axis Machine to Establish Machining Capability for Improved Supply Chain Control and Shorter Delivery Times
  • Patent Bar Exam Candidates Achieve 30% Higher Pass Rates with Wysebridge's 2026 Platform
  • Radiant Floor Heating & Tile: Why More Chester County Homeowners Are Choosing Comfort Over Convention
  • The OpenSSL Corporation Releases Its Annual Report 2025
  • Iranian-Born Engineer Mohsen Bahmani Introduces Propeller-Less Propulsion for Urban Air Mobility
  • Aleen Inc. (C S E: ALEN.U) Advances Digital Wellness Vision with Streamlined Platform Navigation and Long-Term Growth Strategy
  • RimbaMindaAI Officially Launches Version 3.0 Following Strategic Breakthrough in Malaysian Market Analysis
  • 20/20 Institute Launches Updated Vision Correction Procedures Page for Denver & Colorado Springs
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us